Immune Globulin Subcutaneous, Human – Klhw 20% for Primary Humoral Immunodeficiency: An Open-Label, Phase III Study
Open Access
- 17 October 2019
- journal article
- research article
- Published by Taylor & Francis in Immunotherapy
- Vol. 11 (16) , 1371-1386
Abstract
Aim: This prospective, Phase III study assessed the pharmacokinetics (PK), safety and tolerability of immune globulin subcutaneous, human – klhw 20% solution (IGSC-C 20%) in participants with prima... Lay abstract This clinical trial studied a new US FDA-approved product, immune globulin subcutaneous, human – klhw 20% solution (IGSC-C 20%), to treat primary humoral immunodeficiency (PI), a group...Keywords
Funding Information
- Grifols
- Research Triangle Park, NC, USA
- Green Cross
- Therapure
- Kedrion and Prometic
- Adverum
- BioCryst
- CSL Behring
- Optinose
- Shire
- Attenua
- BioCryst
- CSL Behring
- Takeda Pharmaceuticals
This publication has 25 references indexed in Scilit:
- International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of ImmunityJournal of Clinical Immunology, 2017
- The 2017 IUIS Phenotypic Classification for Primary ImmunodeficienciesJournal of Clinical Immunology, 2017
- Update on the use of immunoglobulin in human disease: A review of evidenceJournal of Allergy and Clinical Immunology, 2017
- Practice parameter for the diagnosis and management of primary immunodeficiencyJournal of Allergy and Clinical Immunology, 2015
- Prevalence and Morbidity of Primary Immunodeficiency Diseases, United States 2001–2007Journal of Clinical Immunology, 2014
- Efficacy and safety of Hizentra® in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapyClinical Immunology, 2011
- Subcutaneous immunoglobulin replacement therapy with Hizentra®, the first 20% SCIG preparation: a Practical approachAdvances in Therapy, 2011
- Use of intravenous immunoglobulin in human disease: A review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and ImmunologyJournal of Allergy and Clinical Immunology, 2006
- Intravenous immunoglobulin consensus statement☆☆☆Journal of Allergy and Clinical Immunology, 2001
- The Use of Intravenous Immune Globulin in Immunodeficiency DiseasesNew England Journal of Medicine, 1991